As shown in Figure 5, the expression level of IκBα was significantly decreased in LPS-treated cancer cells, which indicated a desuppression of NF-κB. With the cotreatment with berberine, the degradation of IκBα was prevented and resulted in reduced expression level of p65, accordingly. The gene discussed is NFKBIA; the disease is cancer.